KMS Medisurgi Ltd
₹ 127
1.52%
27 Jun
- close price
About
Incorporated in 2016, KMS Medisurgi Ltd manufactures and sells Surgical Equipment[1]
Key Points
- Market Cap ₹ 41.9 Cr.
- Current Price ₹ 127
- High / Low ₹ 127 / 125
- Stock P/E 95.2
- Book Value ₹ 24.5
- Dividend Yield 0.04 %
- ROCE 8.02 %
- ROE 5.59 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 160 to 111 days.
Cons
- Stock is trading at 5.18 times its book value
- The company has delivered a poor sales growth of 6.16% over past five years.
- Company has a low return on equity of 6.74% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
7.62 | 8.89 | 8.41 | 7.90 | 7.32 | 9.86 | 10.34 | 7.51 | 10.32 | 11.03 | 13.88 | 13.94 | |
7.01 | 8.17 | 7.59 | 6.95 | 6.85 | 9.56 | 9.68 | 7.01 | 9.79 | 10.07 | 13.03 | 13.01 | |
Operating Profit | 0.61 | 0.72 | 0.82 | 0.95 | 0.47 | 0.30 | 0.66 | 0.50 | 0.53 | 0.96 | 0.85 | 0.93 |
OPM % | 8.01% | 8.10% | 9.75% | 12.03% | 6.42% | 3.04% | 6.38% | 6.66% | 5.14% | 8.70% | 6.12% | 6.67% |
0.05 | 0.04 | 0.06 | 0.17 | 0.35 | 0.42 | 0.00 | 0.10 | 0.05 | 0.02 | 0.03 | 0.03 | |
Interest | 0.23 | 0.27 | 0.24 | 0.27 | 0.19 | 0.09 | 0.07 | 0.03 | 0.00 | 0.00 | 0.02 | 0.08 |
Depreciation | 0.39 | 0.41 | 0.34 | 0.49 | 0.45 | 0.43 | 0.41 | 0.33 | 0.29 | 0.32 | 0.25 | 0.27 |
Profit before tax | 0.04 | 0.08 | 0.30 | 0.36 | 0.18 | 0.20 | 0.18 | 0.24 | 0.29 | 0.66 | 0.61 | 0.61 |
Tax % | 50.00% | 50.00% | 53.33% | 38.89% | 50.00% | 40.00% | 38.89% | 45.83% | 24.14% | 13.64% | 24.59% | 27.87% |
0.03 | 0.03 | 0.14 | 0.21 | 0.10 | 0.12 | 0.11 | 0.12 | 0.22 | 0.57 | 0.45 | 0.44 | |
EPS in Rs | 0.60 | 0.60 | 1.17 | 0.88 | 0.30 | 0.36 | 0.33 | 0.36 | 0.67 | 1.73 | 1.36 | 1.33 |
Dividend Payout % | 0.00% | 0.00% | 25.71% | 5.71% | 16.50% | 13.75% | 15.00% | 13.75% | 7.50% | 2.89% | 3.67% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 5% |
5 Years: | 6% |
3 Years: | 11% |
TTM: | 0% |
Compounded Profit Growth | |
---|---|
10 Years: | 31% |
5 Years: | 32% |
3 Years: | 26% |
TTM: | -10% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 31% |
3 Years: | 55% |
1 Year: | 2% |
Return on Equity | |
---|---|
10 Years: | 4% |
5 Years: | 5% |
3 Years: | 7% |
Last Year: | 6% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.50 | 0.50 | 1.20 | 2.40 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 |
Reserves | 0.61 | 0.64 | 2.13 | 1.12 | 2.85 | 2.95 | 3.05 | 3.15 | 3.37 | 3.93 | 4.36 | 4.79 |
3.99 | 2.85 | 2.13 | 2.73 | 1.91 | 1.13 | 1.11 | 1.03 | 0.99 | 0.99 | 0.54 | 0.91 | |
1.91 | 3.21 | 2.60 | 2.36 | 2.14 | 3.15 | 1.64 | 1.86 | 2.17 | 1.51 | 2.65 | 1.34 | |
Total Liabilities | 7.01 | 7.20 | 8.06 | 8.61 | 10.20 | 10.53 | 9.10 | 9.34 | 9.83 | 9.73 | 10.85 | 10.34 |
2.72 | 2.25 | 1.98 | 2.69 | 2.25 | 2.20 | 1.81 | 1.65 | 1.48 | 1.82 | 1.65 | 1.68 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
4.29 | 4.95 | 6.08 | 5.92 | 7.95 | 8.33 | 7.29 | 7.69 | 8.35 | 7.91 | 9.20 | 8.66 | |
Total Assets | 7.01 | 7.20 | 8.06 | 8.61 | 10.20 | 10.53 | 9.10 | 9.34 | 9.83 | 9.73 | 10.85 | 10.34 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.02 | 1.35 | -0.24 | 0.90 | -1.57 | 0.75 | -0.84 | 0.53 | -0.07 | 0.46 | 1.21 | 0.74 | |
-1.82 | 0.05 | -0.03 | -1.10 | 0.11 | -0.31 | 0.01 | -0.10 | -0.12 | -0.66 | -0.51 | -0.96 | |
1.87 | -1.41 | 1.13 | 1.75 | 1.57 | -0.81 | -0.06 | -0.11 | -0.02 | -0.01 | -0.47 | 0.27 | |
Net Cash Flow | 0.06 | -0.01 | 0.86 | 1.56 | 0.10 | -0.37 | -0.88 | 0.32 | -0.21 | -0.21 | 0.23 | 0.05 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 143.22 | 128.10 | 163.19 | 185.73 | 233.36 | 186.94 | 194.15 | 305.22 | 231.31 | 216.42 | 152.00 | 111.02 |
Inventory Days | 23.34 | 50.02 | 17.78 | 6.24 | 85.34 | 82.27 | 62.14 | 45.45 | 42.45 | 70.96 | 87.18 | |
Days Payable | 110.10 | 155.51 | 141.02 | 139.76 | 134.58 | 134.09 | 70.42 | 100.27 | 58.60 | 85.22 | 41.86 | |
Cash Conversion Cycle | 56.46 | 22.61 | 39.94 | 52.21 | 184.13 | 135.12 | 185.86 | 305.22 | 176.49 | 200.27 | 137.74 | 156.34 |
Working Capital Days | 93.41 | 54.20 | 95.05 | 97.95 | 212.92 | 148.07 | 188.85 | 253.22 | 200.54 | 199.54 | 153.84 | 144.01 |
ROCE % | 6.28% | 7.70% | 11.43% | 10.76% | 5.17% | 3.76% | 3.37% | 3.61% | 3.83% | 8.31% | 8.40% | 8.02% |
Documents
Announcements
-
Appointment of Company Secretary and Compliance Officer
21h - Appointed Mrs. Pooja Soni as Company Secretary & Compliance Officer effective 27 June 2025.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday, 27Th June, 2025
21h - Appointment of Mrs. Pooja Soni as Company Secretary & Compliance Officer effective 27 June 2025.
-
Board Meeting Intimation for Intimation Of The Board Meeting
20 Jun - Board meeting on 27 June 2025 to approve new Company Secretary appointment.
-
Submission Of Standalone Audited Financial Results For The Year Ended 31St March, 2025
30 May - KMS Medisurgi reports FY25 audited results with Rs.44L profit; auditor qualified on benefits and stock valuation.
-
Board Meeting Outcome for Submission Of Standalone Audited Financial Results For The Year Ended 31St March, 2025
30 May - Audited FY25 results with Rs.44L profit; qualified audit opinion on benefits and stock reconciliation.
Business Overview:[1]
Company manufactures and undertakes jobwork of coating of various substrates films, cotton fabrics, taffeta silk fabrics with adhesive. It is in the business of marketing and distribution of Surgical Disposable, Haemostat, Medical Devices, Urology Equipment, Surgery equipment, Orthopaedic/ Physiotherapy equipment, Blood Banking Equipment, etc.